Creotech Instruments S.A., a WSE-listed Polish space mission integrator, has completed its demerger, creating two independent companies. On April 1, 2026, the registry court registered an increase in the share capital of Creotech Quantum, formally finalising the spin-off of the quantum segment. Shareholders of Creotech Instruments will automatically receive shares in the new entity on a 1:1 basis. Creotech Quantum’s debut on the Warsaw Stock Exchange is planned for April 17, 2026, with April 2, 2026 being the last trading day to participate in the demerger.
The demerger of Creotech Instruments S.A. is now complete. This marks not only the formal conclusion of an important stage, but above all the beginning of a new chapter for both companies. The spin-off of Creotech Quantum enables a clear separation of our two strategic business areas and allows each to better unlock its full potential. Creotech Quantum will soon debut on the Warsaw Stock Exchange as a specialised entity, ready to accelerate the development of quantum technologies and create value for investors in a rapidly growing segment. At the same time, Creotech Instruments will be able to fully focus on the development of advanced solutions for the space sector, strengthening its position as a mission integrator and technology provider for the European space market. We expect this change to result in greater business transparency, stronger strategic alignment, and long-term value growth for both organisations, said Prof. Grzegorz Brona, CEO of Creotech Instruments S.A.
Creotech Instruments’ quantum technology activities date back to 2012. In April 2025, the Management Board decided to spin off this segment into a separate entity, leading to the registration of Creotech Quantum in June 2025. The demerger plan was announced at the end of August, and its formal completion took place on April 1, 2026. As a result, the two strategic areas – space and quantum – will now be developed by specialised, independent companies, accelerating commercialisation and unlocking the full potential of both organisations.
From the perspective of Creotech Quantum, the completion of the demerger is a symbolic moment – we are moving beyond the organisational phase and shifting to full focus on technology, products and business scaling. We are entering a phase where execution will be key: delivering competitive products, driving their commercialisation, and building a strong position in the global quantum technology ecosystem. We clearly see the growing importance of the areas we specialise in – from secure communication and control systems to high-sensitivity detectors and precise time synchronisation technologies. These are segments where our solutions are already being deployed, and their growth potential is significant. Our goal is to consistently strengthen our technological edge and translate it into tangible market value. The WSE debut of Creotech Quantum will be an important step on this path – but the most exciting part is still ahead, said Dr Anna Kamińska, CEO of Creotech Quantum S.A.
Creotech Quantum S.A. is scaling from key components and initial systems to a full product portfolio, including solutions for quantum cryptography (QKD) and space safety systems (based on the CreoSky camera already in production). The company’s confidence in its growth trajectory is reflected in its incentive programme, which sets clear targets for the next three years. During this period, the company aims to launch full-scale commercialisation of QKD systems for terrestrial networks and single-photon detectors, targeting PLN 100 million in revenue in 2026–2028.
The spin-off of the quantum segment from Creotech Instruments will enable faster commercialisation of developed technologies and easier access to external financing, including programmes dedicated to SMEs.
Demerger terms
The increase in Creotech Quantum’s share capital involves the issuance of 2,854,347 new ordinary Series B shares with a nominal value of PLN 0.10 each (Demerger Shares). These shares will be allocated to Creotech Instruments shareholders on a 1:1 basis – for each share held on the record date, investors will receive one share in Creotech Quantum. The allocation will take place automatically, without any additional action required from shareholders.
The record date has been set for April 8, 2026. Accordingly, April 2, 2026 will be the last trading day on which investors may acquire Creotech Instruments shares entitling them to participate in the demerger. The reference price for the next trading session (April 7) will be adjusted by the value of the spun-off business (16.6%), which will also serve as the reference price for the first trading session of Creotech Quantum shares. Shares in Creotech Quantum will be credited to shareholders’ accounts one day prior to the debut.
Disclaimer
This material (and the information contained herein) is for promotional purposes only and does not constitute an offer to sell or a solicitation or invitation to purchase any financial instruments. The only legally binding document containing information about Creotech Quantum S.A. (the “Company”), the offering of the demerger shares, and their admission to trading on the regulated market operated by the Warsaw Stock Exchange is the prospectus approved by the Polish Financial Supervision Authority and published at: https://creotechquantum.pl/oferta-publiczna/.
Approval of the prospectus should not be understood as an endorsement of the securities offered or admitted to trading. Potential investors should read the prospectus before making an investment decision in order to fully understand the potential risks and rewards associated with an investment in the Company’s securities. Responsibility for the use of the information contained in this material rests solely with the user.